Biotech · Private company
Presage Biosciences
Track this companyFree. Adds Presage Biosciences to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs30From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline30
- 5-FUPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AvelumabPhase 1 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- AZD9592Phase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AZD9592Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AZD9592 + RilvegostomigPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AZD9592 + RilvegostomigPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Carboplatin + PaclitaxelPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 1 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- CIVO devicePhase 1 · Soft Tissue Sarcoma AdultClinicalTrials.gov · fetched Nov 12, 2026
- MK-0482 + PembrolizumabPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- MK-4830 + PembrolizumabPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- MotolimodPhase 1 · HNSCCClinicalTrials.gov · fetched Nov 12, 2026
- Motolimod + NivolumabPhase 1 · HNSCCClinicalTrials.gov · fetched Nov 12, 2026
- Multiple drug microinjectionPhase 1 · Soft Tissue Sarcoma AdultClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · HNSCCClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RilvegostomigPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- RilvegostomigPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SabestomigPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SabestomigPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TAK-676Phase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TAK-676 + CarboplatinPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TAK-981Phase 1 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- TAK-981 + AvelumabPhase 1 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- TAK-981 + CetuximabPhase 1 · Head and Neck CancerClinicalTrials.gov · fetched Nov 12, 2026
- VolrustomigPhase 1 · Head and Neck Squamous Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- VolrustomigPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCCEARLY_PHASE1 · COMPLETED · started May 22, 2024ClinicalTrials.gov NCT06366451 · fetched Nov 12, 2026
- A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid TumorsEARLY_PHASE1 · COMPLETED · started Apr 29, 2024ClinicalTrials.gov NCT06273852 · fetched Nov 12, 2026
- PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STSEARLY_PHASE1 · COMPLETED · started Jun 1, 2022ClinicalTrials.gov NCT06413095 · fetched Nov 12, 2026
- Intratumoral Microdosing of Motolimod in HNSCCEARLY_PHASE1 · TERMINATED · started Oct 15, 2021ClinicalTrials.gov NCT04272333 · fetched Nov 12, 2026
- Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Jul 26, 2021ClinicalTrials.gov NCT04541108 · fetched Nov 12, 2026
- PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCEARLY_PHASE1 · COMPLETED · started Jul 26, 2021ClinicalTrials.gov NCT06062602 · fetched Nov 12, 2026
- Intratumoral Microdosing of TAK-981 in Head and Neck CancerEARLY_PHASE1 · COMPLETED · started Oct 7, 2020ClinicalTrials.gov NCT04065555 · fetched Nov 12, 2026
- Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue SarcomaPHASE1 · COMPLETED · started Dec 15, 2016ClinicalTrials.gov NCT03056599 · fetched Nov 12, 2026